Evidence map›Paper›PMID 21964420›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2012

Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver.

Agnes L Forgacs, Michael N Kent, Meghan K Makley, Bryan Mets, Nicholas DelRaso, Gary L Jahns, Lyle D Burgoon, Timothy R Zacharewski, Nicholas V Reo

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Agnes L ForgacsDepartment of Biochemistry and Molecular Biology, Center for Integrative Toxicology, Michigan State University, East Lansing, Michigan 48824, USA.
Michael N Kent
Meghan K Makley
Bryan Mets
Nicholas DelRaso
Gary L Jahns
Lyle D Burgoon
Timothy R Zacharewski
Nicholas V Reo
Michigan State University · USWright State University · USBAE Systems (United States) · USWright-Patterson Air Force Base · US

Funding

Metabolomic Assessment of Estrogenic Endocrine DisruptorR01ES013927 · NIEHS · MICHIGAN STATE UNIVERSITY · PI ZACHAREWSKI, TIMOTHY R. · 2005 to 2009
$2.8M
NIEHS NIH HHS R01 ES013927
6 · The paper itself

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) elicits a broad spectrum of species-specific effects that have not yet been fully characterized. This study compares the temporal effects of TCDD on hepatic aqueous and lipid metabolite extracts from immature ovariectomized C57BL/6 mice and Sprague-Dawley rats using gas chromatography-mass spectrometry and nuclear magnetic resonance-based metabolomic approaches and integrates published gene expression data to identify species-specific pathways affected by treatment. TCDD elicited metabolite and gene expression changes associated with lipid metabolism and transport, choline metabolism, bile acid metabolism, glycolysis, and glycerophospholipid metabolism. Lipid metabolism is altered in mice resulting in increased hepatic triacylglycerol as well as mono- and polyunsaturated fatty acid (FA) levels. Mouse-specific changes included the induction of CD36 and other cell surface receptors as well as lipases- and FA-binding proteins consistent with hepatic triglyceride and FA accumulation. In contrast, there was minimal hepatic fat accumulation in rats and decreased CD36 expression. However, choline metabolism was altered in rats, as indicated by decreases in betaine and increases in phosphocholine with the concomitant induction of betaine-homocysteine methyltransferase and choline kinase gene expression. Results from these studies show that aryl hydrocarbon receptor-mediated differential gene expression could be linked to metabolite changes and species-specific alterations of biochemical pathways.

Indexed as

Gene Expression ProfilingLiverMetabolomeAnimalsBile Acids and SaltsCD36 AntigensCholesterolCholineFatty Acids, UnsaturatedFemaleGas Chromatography-Mass SpectrometryGene ExpressionGlycolysisLipid MetabolismMagnetic Resonance SpectroscopyMiceBile Acids and SaltsCD36 AntigensCholesterolCholineFatty Acids, UnsaturatedPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonTriglycerides

Identifiers

PMID21964420
PMCPMC3243745
OpenAlexW2131263074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.